Ph.D., Senior Researcher, Doctoral Supervisor, Foreign Academician of Chinese Academy of Sciences, Academician of the American Academy of Sciences, Academician of Academia Sinica, Director of Institute of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Director of Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, the first and current director of Institute of Neuroscience, Chinese Academy of Sciences, the head of the neuroplasticity research group. Since 2011, he has been the chief scientist of the "Neural Foundation of Human Intelligence" in the 973 Program for Major Scientific Issues of the Ministry of Science and Technology. Since 2012, he has served as the Chief Scientific Advisor of the Strategic Leadership Technology Special Project (Class B) "Brain Function Linkage Map" of the Chinese Academy of Sciences. He was awarded the American AAAS Fellow (2001), the American Ameritec Award, the Wurui Society Award, the Honorary Doctorate of École Normale Supérieure and the Hong Kong University of Science and Technology, the International Science and Technology Cooperation Award of the People's Republic of China, Qiushi Outstanding Scientist Award, the Outstanding Science and Technology Achievement Award of the Chinese Academy of Sciences, etc.

Jeremy Douglas is the Regional Representative of the United Nations Office on Drugs and Crime (UNODC) for Southeast Asia and the Pacific overseeing and managing operations and strategy from Myanmar to the Pacific in the areas of the rule of law, non-traditional security threats, law enforcement, criminal justice and drug-related supply and health issues. He is also the UNODC liaison to China, Korea, Japan and Mongolia and to regional organisations including the Association of Southeast Asian Nations (ASEAN) and the Pacific Islands Forum Secretariat (PIFS).

He is a professor of National Drug &Alcohol Research Centre, University of New South Wales. His main research areas are drug and alcohol-related research. His main research interests are opioid dependence management, psychostimulant replacement therapy, juvenile drug dependence treatment, and psychostimulant and opioid's effects on cognitive function, and other clinical trials. He has published more than 100 articles and books on topics such as assessment, characterization, and treatment of issues such as emotion, cognition, psychology, and neuropsychology. He is the editor of the Cochrane Drug and Alcohol Evaluation Group, assistant editor of the International Journal “Addiction”, and executive editor of “Drug and Alcohol Review”.

Professor, Chief Physician, Master's Supervisor, Associate Dean of Nanjing Brain Hospital Affiliated to Nanjing Medical University, Director of Cognitive and Behavioral Therapy Institute of Nanjing Medical University, Director of Department of Psychiatry, Standing Committee Member of Chinese Medical Association Psychiatry Branch (CSP), Vice President of Chinese Medical Doctor Association Psychiatrist Branch (CPA), Chairman of the Cognitive and Behavioral Therapy Committee of Chinese Mental Health Association, Chairman of OCD committee of Chinese Medical Doctor Association Psychiatrist Branch, Chairman of the Asian Cognitive and Behavioral Therapy Association, National Key Clinical Specialist, Leader of key disciplines in Jiangsu Province, State Council Special Allowance, young and middle-aged expert with outstanding contributions in Jiangsu Province, and outstanding psychiatrist of Chinese Medical Doctor Association Psychiatrist Branch. He has long been engaged in the treatment of psychological disorders such as depression, anxiety, insomnia and psychological counseling and psychotherapy.